EssilorLuxottica Financials
| EL Stock | EUR 286.90 1.50 0.52% |
EssilorLuxottica |
Understanding current and past EssilorLuxottica Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of EssilorLuxottica's financial statements are interrelated, with each one affecting the others. For example, an increase in EssilorLuxottica's assets may result in an increase in income on the income statement.
Please note, the presentation of EssilorLuxottica's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, EssilorLuxottica's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of EssilorLuxottica's management manipulating its earnings.
EssilorLuxottica Stock Summary
EssilorLuxottica competes with Pernod Ricard, LOreal SA, Kering SA, Hermes International, and Dassault Systemes. EssilorLuxottica Socit anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses North America, Europe, Asia, Oceania, Africa, Latin America, and internationally. The company was founded in 1849 and is headquartered in Paris, France. ESSILORLUXOTTICA is traded on Paris Stock Exchange in France.| Foreign Associate | USA |
| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0000121667 |
| Business Address | 1-5 rue Paul |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.essilorluxottica.com |
| Phone | 33 1 49 77 42 16 |
| Currency | EUR - Euro |
You should never invest in EssilorLuxottica without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of EssilorLuxottica Stock, because this is throwing your money away. Analyzing the key information contained in EssilorLuxottica's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
EssilorLuxottica Key Financial Ratios
EssilorLuxottica's financial ratios allow both analysts and investors to convert raw data from EssilorLuxottica's financial statements into concise, actionable information that can be used to evaluate the performance of EssilorLuxottica over time and compare it to other companies across industries.| Return On Equity | 0.0615 | |||
| Return On Asset | 0.0336 | |||
| Target Price | 188.4 | |||
| Beta | 0.88 | |||
| Z Score | 5.4 |
EssilorLuxottica Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EssilorLuxottica's current stock value. Our valuation model uses many indicators to compare EssilorLuxottica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EssilorLuxottica competition to find correlations between indicators driving EssilorLuxottica's intrinsic value. More Info.EssilorLuxottica S A is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.55 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for EssilorLuxottica S A is roughly 1.83 . Comparative valuation analysis is a catch-all model that can be used if you cannot value EssilorLuxottica by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for EssilorLuxottica's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.EssilorLuxottica S Systematic Risk
EssilorLuxottica's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. EssilorLuxottica volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on EssilorLuxottica S correlated with the market. If Beta is less than 0 EssilorLuxottica generally moves in the opposite direction as compared to the market. If EssilorLuxottica Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one EssilorLuxottica S is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of EssilorLuxottica is generally in the same direction as the market. If Beta > 1 EssilorLuxottica moves generally in the same direction as, but more than the movement of the benchmark.
EssilorLuxottica March 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of EssilorLuxottica help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of EssilorLuxottica S A. We use our internally-developed statistical techniques to arrive at the intrinsic value of EssilorLuxottica S A based on widely used predictive technical indicators. In general, we focus on analyzing EssilorLuxottica Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build EssilorLuxottica's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.8869 | |||
| Information Ratio | 0.2685 | |||
| Maximum Drawdown | 9.96 | |||
| Value At Risk | (1.20) | |||
| Potential Upside | 2.0 |
Complementary Tools for EssilorLuxottica Stock analysis
When running EssilorLuxottica's price analysis, check to measure EssilorLuxottica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EssilorLuxottica is operating at the current time. Most of EssilorLuxottica's value examination focuses on studying past and present price action to predict the probability of EssilorLuxottica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EssilorLuxottica's price. Additionally, you may evaluate how the addition of EssilorLuxottica to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |